BRUKER CORPORATION Proceeds from Long-Term Debt Issued
BRUKER CORPORATION (BRKR) reported Proceeds from Long-Term Debt Issued of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfLongTermDebt · last filed 2026-08-05
- BRUKER CORPORATION proceeds from issuance of long-term debt for the quarter ending 2026-06-30 was $0.00.
- BRUKER CORPORATION proceeds from issuance of long-term debt for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- BRUKER CORPORATION proceeds from issuance of long-term debt for the quarter ending 2025-12-31 was $600.00K, a 50.00% decline year-over-year.
- BRUKER CORPORATION proceeds from issuance of long-term debt for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- BRUKER CORPORATION proceeds from issuance of long-term debt for fiscal 2025 was $3.50M, a 99.64% decline from fiscal 2024.
- BRUKER CORPORATION proceeds from issuance of long-term debt for fiscal 2024 was $973.70M, a 48585.00% increase from fiscal 2023.
- BRUKER CORPORATION proceeds from issuance of long-term debt for fiscal 2023 was $2.00M, a 566.67% increase from fiscal 2022.
- BRUKER CORPORATION proceeds from issuance of long-term debt for fiscal 2022 was $300.00K, a 99.94% decline from fiscal 2021.
| Period end | Proceeds from Issuance of Long-term Debt 3 month | Proceeds from Issuance of Long-term Debt 6 month | Proceeds from Issuance of Long-term Debt 6 month as first filed | Proceeds from Issuance of Long-term Debt 9 month | Proceeds from Issuance of Long-term Debt 9 month as first filed | Proceeds from Issuance of Long-term Debt 12 month | Proceeds from Issuance of Long-term Debt 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $0.00 10-Q · filed 2026-08-05 | $600.00K derived: sum of 3 quarters · filed 2026-08-05 | $600.00K derived: sum of 4 quarters · filed 2026-08-05 | |||
| 2026-03-31 | $0.00 10-Q · filed 2026-05-07 | $600.00K derived: sum of 2 quarters · filed 2026-05-07 | $600.00K derived: sum of 3 quarters · filed 2026-05-07 | $600.00K derived: sum of 4 quarters · filed 2026-08-05 | |||
| 2025-12-31 | $600.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $600.00K derived: sum of 2 quarters · filed 2026-02-27 | $600.00K derived: sum of 3 quarters · filed 2026-08-05 | $3.50M 10-K · filed 2026-02-27 | |||
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $0.00 derived: sum of 2 quarters · filed 2026-08-05 | $2.90M 10-Q · filed 2025-11-05 | $4.10M derived: sum of 4 quarters · filed 2026-08-05 | |||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $2.90M 10-Q · filed 2026-08-05 | $4.10M derived: sum of 3 quarters · filed 2026-08-05 | $170.90M derived: sum of 4 quarters · filed 2026-08-05 | |||
| 2025-03-31 | $2.90M 10-Q · filed 2026-05-07 | $4.10M derived: sum of 2 quarters · filed 2026-05-07 | $170.90M derived: sum of 3 quarters · filed 2026-05-07 | $976.60M derived: sum of 4 quarters · filed 2026-05-07 | |||
| 2024-12-31 | $1.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $168.00M derived: sum of 2 quarters · filed 2026-02-27 | $973.70M derived: sum of 3 quarters · filed 2026-02-27 | $973.70M 10-K · filed 2026-02-27 | |||
| 2024-09-30 | $166.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $972.50M derived: sum of 2 quarters · filed 2025-11-05 | $972.50M 10-Q · filed 2025-11-05 | $4.80M 10-Q · filed 2024-11-07 | $971.30M derived: sum of 4 quarters · filed 2026-02-27 | ||
| 2024-06-30 | $805.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $805.70M 10-Q · filed 2025-08-06 | $4.10M 10-Q · filed 2024-08-09 | $804.50M derived: sum of 3 quarters · filed 2026-02-27 | $804.90M derived: sum of 4 quarters · filed 2026-02-27 | ||
| 2024-03-31 | $0.00 10-Q · filed 2025-05-07 | -$1.20M derived: sum of 2 quarters · filed 2026-02-27 | -$800.00K derived: sum of 3 quarters · filed 2026-02-27 | ||||
| 2023-12-31 | -$1.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$800.00K derived: sum of 2 quarters · filed 2026-02-27 | $2.00M 10-K · filed 2026-02-27 | ||||
| 2023-09-30 | $400.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $3.20M 10-Q · filed 2024-11-07 | |||||
| 2023-06-30 | $2.80M 10-Q · filed 2024-08-09 | ||||||
| 2022-12-31 | $300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $200.00K derived: sum of 2 quarters · filed 2025-03-03 | $300.00K 10-K · filed 2025-03-03 | $0.00 10-K · filed 2023-03-01 | |||
| 2022-09-30 | -$100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $0.00 10-Q · filed 2023-11-09 | |||||
| 2022-06-30 | $100.00K 10-Q · filed 2023-08-09 | ||||||
| 2021-12-31 | $492.80M 10-K · filed 2023-03-01 | ||||||
| 2020-12-31 | $0.00 10-K · filed 2023-03-01 | ||||||
| 2019-12-31 | $597.90M 10-K · filed 2022-02-28 | ||||||
| 2009-12-31 | $1.60M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |